PERTH, WA – News Direct – 29 September 2022 – Brookside Energy Ltd (ASX:BRK) managing director David Prentice speaks with Andrew Scott about securing a rig for the Wolf Pack Well. This is a vital precursor to starting the Phase Two development drilling program in the SWISH Area of Interest in Oklahoma’s world-class Anadarko Basin. “Latshaw provided us with the great people and equipment for the drilling of our very first operated well in SWISH – our wonderfully successful Jewell Well,” says Prentice.
Share this:
- Click to share on X (Opens in new window) X
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Pocket (Opens in new window) Pocket
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print
Related Posts
Free Healthcare Webinar: Patient Journey & the Digital Twins
JOHANNESBURG, SOUTH AFRICA – Media OutReach – 6 April 2021 – Delivering high-quality care for patients starts by connecting data…
Share this:
- Click to share on X (Opens in new window) X
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Pocket (Opens in new window) Pocket
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print
ROSEN, A LEADING LAW FIRM, Encourages Latch, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LTCH, LTCHW
New York, New York – Newsfile Corp. – September 17, 2022 – WHY: Rosen Law Firm, a global investor rights…
Share this:
- Click to share on X (Opens in new window) X
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Pocket (Opens in new window) Pocket
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print
A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Targeted therapy regimen, BRAFTOVI® (encorafenib) in combination with cetuximab, included on MOH Cancer Drug List, for the treatment of adult…
Share this:
- Click to share on X (Opens in new window) X
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Pocket (Opens in new window) Pocket
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print